Clinical characteristics, hospitalisation and mortality rates of COVID-19 among patients with coeliac disease in the USA: a multicentre network study

Mansoor, Emad; Alikhan, Muhammed Mustafa; Perez, Abe; Schlick, Kayla; Saleh, Mohannad Abou; Rubio–Tapia, Alberto

doi:10.1136/gutjnl-2021-325930

Cited by 7 publications

(7 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We read with interest the work by Mansoor et al 1 regarding the outcomes of COVID-19 in coeliac disease. The impact of pre-existing chronic liver diseases on COVID-19 outcomes has been largely evaluated, [2][3][4] and consequently specific recommendations have been made in these patients.…”

mentioning

confidence: 99%

“…5 However, the relationship between primary biliary cholangitis (PBC) and SARS-CoV-2 remains unknown. 6 We aimed to determine (1) the cumulative incidence of SARS-CoV-2 infection in a population of patients with PBC, comparing with the general Spanish cumulative incidence by the end of April 2021; (2) the baseline factors associated with a higher susceptibility to SARS-CoV-2 infection; and (3) the baseline factors associated with COVID-19-related hospitalisation.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes

Ampuero

Lucena

Hernández‐Guerra

et al. 2021

Gut

View full text Add to dashboard Cite

mentioning

confidence: 99%

mentioning

confidence: 99%

Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes

Ampuero

Lucena

Hernández‐Guerra

et al. 2021

Gut

View full text Add to dashboard Cite

“…930 articles were further excluded after considering the title and abstract, generating 68 papers for satisfactory article review for plausible consideration in this analysis. Eventually, 11 articles consisting of 44,378 celiac patients were incorporated into this meta‐analysis based on exhaustive evaluation and inclusion criteria 8,14–23 . The baseline characteristics of the incorporated studies are summarised in Table 1.…”

Section: Resultsmentioning

confidence: 99%

“…Eventually, 11 articles consisting of 44,378 celiac patients were incorporated into this meta-analysis based on exhaustive evaluation and inclusion criteria. 8,[14][15][16][17][18][19][20][21][22][23] The baseline characteristics of the incorporated studies are summarised in Table 1. Four of these included studies were from Italy, followed by the USA with two reports and one from Iran, Sweden, and the United Kingdom.…”

Section: Characteristics Of the Included Studiesmentioning

confidence: 99%

Prevalence and clinical outcomes of COVID‐19 in patients with pre‐existing celiac disease: A systematic review and meta‐analysis

Rathore¹,

Velasquez‐Botero

Nieto‐Salazar

et al. 2023

Reviews in Medical Virology

View full text Add to dashboard Cite

There is a scarcity of scientific evidence addressing the outcomes of COVID‐19 in celiac disease (CD) patients. This systematic review and meta‐analysis aimed to evaluate the correlation between pre‐existing CD and COVID‐19. A rigorous literature search was conducted using multiple databases. All eligible observational studies were included from around the globe. The random effect model calculated the pooled prevalence and associated 95% confidence intervals (CI). Mantel‐Haenszel odds ratios were produced to report the overall effect size using random effect models for severity and mortality outcomes. Funnel plots, Egger regression tests, and Begg‐Mazumdar's rank correlation test were used to appraise publication bias. Data from 11 articles consisting of 44,378 CD patients were obtained. Overall pooled random‐effects estimate of SARS‐CoV‐2 infection in CD patients was 4.25% (95% CI, I2 = 98%). Our findings also indicated that pre‐existing CD was not associated with an increased risk of hospitalisation with COVID‐19 illness (OR = 1.04, 95% CI 0.87–1.24, I2 = 0%) and mortality due to illness (OR = 0.92, 95% CI 0.56–1.5, I2 = 45%) compared with patients without pre‐existing CD. No significant publication bias was evident in the meta‐analysis. The preliminary data from our analysis suggest that SARS‐CoV‐2 infection in patients with pre‐existing CD is not associated with an increased risk of hospitalisation or mortality. Additional studies are required to overcome the restrictions of the limited data available at present.

show abstract

“…Studies conducted prior to the availability of COVID-19 vaccines found that hospitalization rate and fatality rate were similar among individuals with celiac disease when compared to the general population. 14 – 16 A population-based study in Sweden indicated no increased risk of hospitalization for COVID-19 in patients with celiac disease compared to matched controls. 15 In contrast, a similar population-based study in Sweden study showed that individuals diagnosed with inflammatory bowel disease were at an increased risk of hospitalization due to COVID-19.…”

Section: Risk Of Contraction Of Covid-19 and Risk Of Severe Infection...mentioning

confidence: 99%

COVID-19 and celiac disease: a review

Cohen

Lebwohl

2023

Therap Adv Gastroenterol

View full text Add to dashboard Cite

The aim of this review is to broadly cover how the COVID-19 pandemic has affected individuals with celiac disease, including perceived risk, risk of contraction or severe infection, considerations regarding vaccination, access to gluten-free food during the pandemic, and possible long-term changes to the practice of celiac disease management spurred by the pandemic. While initially there was increased perceived risk about COVID-19 in the celiac disease population, studies have found that individuals with celiac disease are not at an increased risk of contracting or having a severe course compared to the general population. There is not yet evidence that COVID-19 infection will lead to an increase in celiac disease incidence, though more research on this topic with longer-term follow-up is necessary to make this determination. Limited access to in-person visits led to an increase in telemedicine, which was adopted swiftly by this patient population and may offer improved access in the long term. In summary, individuals with celiac disease do not appear to be at an increased risk of contracting COVID-19 or having a more severe disease course.

show abstract

Clinical characteristics, hospitalisation and mortality rates of COVID-19 among patients with coeliac disease in the USA: a multicentre network study

Cited by 7 publications

References 5 publications

Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes

Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes

Prevalence and clinical outcomes of COVID‐19 in patients with pre‐existing celiac disease: A systematic review and meta‐analysis

COVID-19 and celiac disease: a review

Contact Info

Product

Resources

About